Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development

https://doi.org/10.1016/j.modgep.2005.11.001Get rights and content

Abstract

Cerebral Cavernous Malformation (CCM) is a disease characterized by capillary-venous lesions mostly located in the central nervous system. It occurs both as a sporadic and hereditary autosomal dominant condition. Three CCM genes have been identified and shown to encode the KRIT1 (CCM1), MGC4607 (CCM2) and PDCD10 (CCM3) proteins whose functions are so far unknown. In an attempt to get some insight into the role of the 3 CCM genes, we used in situ hybridization to conduct a comparative analysis of their expression pattern at several time points during murine embryonic, postnatal and adult stages particularly within the central nervous system. A strong expression of the 3 Ccm genes was detected in the various neuronal cell layers of the brain, cerebellum and spinal cord, from embryonic to adult life. By E14.5 a moderate labelling was observed in the heart, arterial and venous large vessels with all 3 Ccm probes. Ccm2 and Ccm3 mRNAs, but not Ccm1, were clearly detected within meningeal and parenchymal cortical vessels at P8. This expression was no more detected by P19 and in adult murine brain, strongly suggesting a role for these 2 proteins in the intensive angiogenesis process occuring within the central nervous system during this period.

Section snippets

Results and discussion

Cerebral Cavernous Malformation (CCM) is vascular malformation histologically characterized mainly of abnormally enlarged capillary cavities lined by endothelial cells without intervening brain parenchyma (Russel and Rubinstein, 1989). Clinical manifestations include cerebral hemorrhages and seizures. CCM occurs both as a sporadic (80% cases) and familial autosomal dominant condition (20% cases). Familial cases are characterized by the presence of multiple cerebral lesions, which may be

Experimental procedures

The procedures used in this study have been previously described (Sibony et al., 1995, Denier et al., 2002).

Acknowledgements

We thank Anne Joutel for helpful discussion and Valérie Domenga for technical advice. NP is a recipient from Fondation Lefoulon-Delalande fellowship. This work was supported by INSERM, GIS Maladies Rares (AO 2002-2004) and Programme Hospitalier de Recherche Clinique Régional (PHRC AOR03031).

References (25)

  • O. Guzeloglu-Kayisli et al.

    KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex

    Neurosurgery

    (2004)
  • H. Kehrer-Sawatzki et al.

    Mutation and expression analysis of the KRITI gene associated with cerebral cavernous malformations (CCMI)

    Acta Neuropathol. (Berl)

    (2002)
  • Cited by (0)

    View full text